spacer
The Healthcare Sales & Marketing Network celebrates 24 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ThromCat 

 HSMN NewsFeed - 20 Aug 2009
Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
Devices Regenerative Medicine
 HSMN NewsFeed - 7 Aug 2009
Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
Devices Distribution
 HSMN NewsFeed - 23 Jun 2009
ThromCat(R) XT(TM) Thrombectomy Catheter System Receives CE Mark
Devices Interventional Regulatory
 HSMN NewsFeed - 23 Jun 2009
Spectranetics Receives CE Mark Approval for ThromCat(R)XT
Devices Interventional Regulatory
 HSMN NewsFeed - 2 Jun 2008
Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics
Devices Interventional Acquisitions
 HSMN NewsFeed - 2 Jun 2008
Spectranetics Announces Closing of Transaction to Acquire Endovascular Business of Kensey Nash
Devices Interventional Acquisitions
 HSMN NewsFeed - 13 May 2008
Spectranetics Acquires Endovascular Business of Kensey Nash
Devices Interventional Acquisitions
 HSMN NewsFeed - 13 May 2008
Kensey Nash Announces Sale of Endovascular Business and Strategic Partnership With Spectranetics
Devices Interventional Acquisitions
 HSMN NewsFeed - 18 Jun 2007
Kensey Nash Announces Results of EU Coronary Study Using the Thromcat(TM) Thrombectomy Catheter System
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
Kensey Nash Receives CE Mark Approval for New ThromCat(TM) Thrombectomy Catheter System
Devices Interventional
 HSMN NewsFeed - 24 Jul 2006
Kensey Nash Receives CE Mark Approval for QuickCat(TM) Extraction Catheter
Devices Regulatory Interventional
 HSMN NewsFeed - 12 Jul 2006
Kensey Nash Receives FDA 510(k) Clearance for TriActiv FX(R) Embolic Protection System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 26 May 2006
Kensey Nash Announces Acquisition of Assets of IntraLuminal Therapeutics, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 27 Apr 2006
Kensey Nash Receives FDA 510(k) Clearance for New ThromCat(TM) Thrombectomy Catheter System
Devices FDA
 HSMN NewsFeed - 26 Apr 2006
Kensey Nash Announces Completion of Carotid Pilot Trial Using the TriActiv(R) ProGuard(TM) System
Devices Interventional
 HSMN NewsFeed - 10 Mar 2006
Kensey Nash Receives FDA 510(k) Clearance for QuickCat(TM) Extraction Catheter
Devices Interventional FDA
 HSMN NewsFeed - 7 Mar 2006
Kensey Nash Announces Low 3.2% MACE Rate Achieved Using New TriActiv FX(R) Embolic Protection System
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Jan 2006
Kensey Nash Submits TriActiv FX(R) Embolic Protection System 510(k) Application to FDA
Devices Interventional FDA
 HSMN NewsFeed - 12 Jan 2006
Kensey Nash Submits QuickCat(TM) Extraction Catheter 510(k) Application to FDA
Devices FDA
 HSMN NewsFeed - 5 Jan 2006
Kensey Nash Submits ThromCat(TM) Thrombectomy System 510(k) Application to FDA
Devices Interventional FDA
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.